Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

3M Drug Delivery Systems Division provides new pain management platform

Feb. 8, 2000

Taisho discloses new agents for CRF-related diseases

Feb. 7, 2000

Titan establishes collaboration with Schering AG for Parkinson's disease therapy

Feb. 7, 2000

Novel kinase-inhibitory series for AD and cancer presented by Bayer

Feb. 7, 2000

Second group dosed in early clinical evaluation of Axonyx's phenserine

Feb. 7, 2000

Novel analgesic compounds reported by Gruenenthal

Feb. 4, 2000

Cognetix, Elan team up to develop novel analgesic/drug delivery system

Feb. 4, 2000

Avonex MS trial stopped early, results positive

Feb. 4, 2000

Wyeth-Ayerst makes EAAT-related milestone payment to Neurocrine Biosciences

Feb. 4, 2000

Lilly describes 5-HT1F agonists as potential antimigraine agents

Feb. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...